Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer.

Viale G, Basik M, Niikura N, Tokunaga E, Brucker S, Penault-Llorca F, Hayashi N, Sohn J, Teixeira de Sousa R, Brufsky AM, O'Brien CS, Schmitt F, Higgins G, Varghese D, James GD, Moh A, Livingston A, de Giorgio-Miller V.

Open source

DOI
10.1016/j.esmoop.2023.101615
Published
2023-08-08
Container
ESMO Open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.esmoop.2023.101615,
  title = {Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer.},
  author = {Viale G and  Basik M and  Niikura N and  Tokunaga E and  Brucker S and  Penault-Llorca F and  Hayashi N and  Sohn J and  Teixeira de Sousa R and  Brufsky AM and  O'Brien CS and  Schmitt F and  Higgins G and  Varghese D and  James GD and  Moh A and  Livingston A and  de Giorgio-Miller V.},
  year = {2023},
  journal = {ESMO Open},
  doi = {10.1016/j.esmoop.2023.101615},
  url = {https://doi.org/10.1016/j.esmoop.2023.101615}
}

RIS

TY  - JOUR
TI  - Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer.
AU  - Viale G
AU  -  Basik M
AU  -  Niikura N
AU  -  Tokunaga E
AU  -  Brucker S
AU  -  Penault-Llorca F
AU  -  Hayashi N
AU  -  Sohn J
AU  -  Teixeira de Sousa R
AU  -  Brufsky AM
AU  -  O'Brien CS
AU  -  Schmitt F
AU  -  Higgins G
AU  -  Varghese D
AU  -  James GD
AU  -  Moh A
AU  -  Livingston A
AU  -  de Giorgio-Miller V.
PY  - 2023
JO  - ESMO Open
DO  - 10.1016/j.esmoop.2023.101615
UR  - https://doi.org/10.1016/j.esmoop.2023.101615
ER  - 

APA

G, V., M, B., N, N., E, T., S, B., F, P., N, H., J, S., R, T. D. S., AM, B., CS, O., F, S., G, H., D, V., GD, J., A, M., A, L., & V., D. G. (2023). Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer.. ESMO Open. https://doi.org/10.1016/j.esmoop.2023.101615

Source records